Cholecystokinin (CCK) is secreted from specific enteroendocrine cells of the upper small intestine upon ingestion of a meal. In addition to nutrients, endogenously produced factors appear to act within the gut lumen to stimulate CCK release. One such factor is a trypsin-sensitive CCK-releasing peptide found in pancreatic juice, known as monitor peptide. This peptide is active within the intestinal lumen and is hypothesized to stimulate CCK secretion by interacting directly with the CCK cell. We have found that monitor peptide releases CCK from isolated rat intinal mucosal cells and that this effect is dependent upon extracellular calcium. In the present study, we used monitor peptide as a tool for isolating CCK cells from a population of small intestinal mucosal cells. Dispersed rat intestinal mucosal cells were loaded with the calcium-sensitive fluorochrome Indo-1, and CCK secretory cells were identified spectrofluorometrically by their change in fluorescence when stimulated with monitor peptide. Cells demonstrating a change in their emission fluorescence ratio were sorted using a fluorescenceactivated cell sorter. More than 90% of the sorted cells stained positively for CCK with immunohistochemical staining. Furthermore, sorted cells secreted CCK when stimulated with membrane-depolarizing concentrations of potassium chloride, dibutyryl cAMP, calcium ionophore, and monitor peptide.
These findings indicate that functional intestinal CCK cells can be highly enriched using fluorescence-activated cell sorting. Furthermore, monitor peptide appears to interact directly with CCK cells to signal CCK release through an increase in intracellular calcium.
Cholecystokinin (CCK) is an established gastrointestinal hormone that is localized in discrete mucosal endocrine cells of the upper small intestine (1) . CCK is secreted from the intestine in response to eating and has effects on many digestive processes including gallbladder contraction, pancreatic secretion, bowel motility, and perhaps satiety (2) . Although much is known about the actions of CCK, many aspects regarding the cellular mechanisms regulating its secretion have not been characterized. CCK release can be regulated in several different ways. It is hypothesized that foods in the intestinal lumen that come in contact with the apical surface of the CCK cell may affect CCK release directly. In addition, it is likely that neural and hormonal factors also modulate CCK secretion (3) (4) (5) (6) (7) (8) (9) . CCK secretion is also under negative feedback regulation by pancreatic secretion whereby active proteases in the intestinal lumen inhibit CCK secretion, and inactivation of intestinal proteases or binding of proteases by substrates such as protein or trypsin inhibitor stimulates CCK secretion (10) (11) (12) .
Recently, it has been proposed (13) (14) (15) (16) ) that CCK secretion is regulated by two types of trypsin-sensitive "CCK releasing factors." One type of releasing factor is produced in the upper small intestine and appears to be responsible for the pronounced increase in CCK secretion that occurs with diversion of bile and pancreatic juice (13, 14) . Therefore, it is likely that this intestinal CCK releasing factor is physiologically important in the regulation of CCK secretion. However, this factor has not yet been isolated and its chemical structure is not known. A second releasing factor named monitor peptide has been identified in high amounts in pancreatic juice (15) (16) (17) . Monitor peptide is a 61-amino acid peptide that is structurally related to a 56-amino acid protein that possesses trypsin inhibitor-like activity-hence, the name pancreatic secretory trypsin inhibitor (PSTI). However, the ability of monitor peptide to stimulate CCK release is independent of its trypsin inhibitor activity and the 56-amino acid PSTI itself does not stimulate CCK secretion. Therefore, monitor peptide appears to directly stimulate the CCK cell by interacting with the apical surface possibly through a membrane receptor.
Most studies of CCK secretion have been conducted in whole animals, intestinal segments, or only partially enriched preparations of CCK cells (2, (18) (19) (20) . Accordingly, it has not been possible to study intracellular mechanisms regulating CCK release without possible interference from other hormones, neurotransmitters, or paracrine agents. We have recently developed a method for studying hormone secretion from rat intestinal mucosal cells in a perifusion apparatus. In this preparation, CCK cells represent <1% of the mucosal cell population. Nevertheless, cells release CCK in response to calcium ionophores and monitor peptide. Moreover, the ability of monitor peptide to stimulate CCK secretion was dependent upon extracellular calcium. Therefore, we postulated that monitor peptide is a specific secretagogue for the CCK cell and that one mechanism by which monitor peptide affects the CCK cell is by increasing intracellular calcium ([Ca2+]i).
Calcium-sensitive fluorochromes that accumulate intracellularly are sensitive to changes in [Ca2+]1 (21, 22 (23) . This buffer was enriched with mixed amino acids and was equilibrated to pH 7.4 in an atmosphere of 95% 02/5% Co2. Tissue was then placed in 10 ml of KHB with 1.2 mM CaCl2 containing 1 mg of collagenase and agitated by gentle inversion for 10 min. After this incubation, the suspension was centrifuged for 3 min at 100 x g. The supernate was discarded and the pellet (containing cells) was resuspended in 2 ml of Hepes buffer containing 10 mM Hepes, 1.2 mM CaCl2, 103 mM NaCl, 1 mM NaH2PO4, 4.7 mM KCl, 0.56 mM MgCl2, 11.1 mM glucose, 0.1% bovine serum albumin, and mixed amino acids (adjusted to pH 7.4). At this point, single cells were identified microscopically. For perifusion studies, these cells were added to a vial containing 2.5 ml of Sephadex G-50 medium resin that had been preswollen in saline overnight at 4°C. The cells and resin were mixed for 1 min.
Perifusion of Intestinal Mucosal Cells. A perifusion apparatus was modified as described (24, 25) . Cells were loaded into a perifusion chamber consisting of a 3-ml disposable plastic syringe whose plunger was perforated with a 19-gauge needle connected to polyethylene tubing. Two to 2.5 ml of Sephadex resin/cell mixture was layered over a double layer of 5-,um nylon filters. Perifusion solutions were made of Hepes buffer (pH 7.4) supplemented as described above and bubbled with 100% 02. Solutions were maintained in a 37°C water bath and pumped through silicone-coated polyethylene tubing (0.02 inch, inner diameter; 0.037 inch, outer diameter; 1 inch = 2.54 cm) by a peristaltic pump through the perifusion column at a rate of 1 ml/min. The tip of the syringe was fitted with a 19-gauge needle, which, in turn, was attached to polyethylene tubing that emptied into a fraction collector.
Once loaded into the column, cells were equilibrated for 1 h with Hepes buffer to obtain a steady baseline level of CCK release. The perifusion medium could be changed instantly by means of switching flasks. In this way, perifusion medium containing different reagents were sequentially perifused through the chamber containing the mucosal cells. Column fractions were passed through octadecylsilylsilica (C18 SepPak) cartridges prewashed with 5 ml of methanol and 20 ml ofdeionized water, to concentrate CCK (11) . Cartridges were then washed with 20 ml of deionized water and stored at -20°C or used immediately for assay.
All periods of stimulation with secretagogues were 15 min long followed by a period of at least 20 min during which the column was perifused with Hepes buffer. Fractions for assay were collected at 5-min intervals. The dead space of the system was 4.6 ml; therefore, the effect of a test substance lagged approximately one fraction behind its initiation. All solutions to be perifused were maintained at 370C in a water bath and were oxygenated with 10O% 02. peptide produced a prompt increase in CCK release that persisted for the duration of exposure (Fig. 1) . The ability of monitor peptide to stimulate CCK release was dependent upon extracellular calcium ion concentration since monitor peptide had no effect on CCK release in calcium-free buffer.
Several controls were used to confirm that the CCK activity measured by bioassay was an accurate estimate of the amount of CCK bioactivity present in column fractions. Cell Sorting with Monitor Peptide. Dispersed mucosal cells were loaded with Indo-1 AM, washed, and resuspended in Hepes buffer containing 1.2 mM CaC12. Basal fluorescence ratios ranged between 0 and 0.4 (n = 10) and remained stable for up to 1 h. A change in fluorescence ratio was observed with addition of monitor peptide. A concentration of 10 nM was sufficient to detect a change in fluorescence ratio in 15 of 17 cell preparations. The fluorescence signal increased within 30 sec of adding monitor peptide and was sustained for at least 30 min during which time cells were separated by selecting a gating ratio over that ofbasal (Fig. 2) cells) stained positively for CCK ( Fig. 3 A and B) . However, after sorting 92.9% of sorted cells (n = 225 cells) stained positively for CCK (Fig. 3C) . CCK Secretion from Purified CCK Cells. The ability of enriched CCK cells to secrete hormone in response to secretagogue stimulation was tested by placing cells into short-term overnight culture with Sephadex G-50 beads. The cell and resin mixture was then introduced into a perifusion column for measuring dynamic hormone secretion. Enriched CCK cells were stimulated with four types of potential secretagogues (Fig. 4) . Cells were continuously perifused with Hepes buffer and then stimulated with 30 nM monitor peptide. After an intervening period with perifusion of buffer alone, cells were exposed to buffer to which 5 ,uM dibutyryl cAMP was added. This was followed by Hepes in which 52 mM KCl was substituted for NaCl. Finally, the effects of the calcium ionophore A23187 (1 .M) on CCK release was tested. All four agents produced significant increases in CCK release. In between stimulations, CCK levels returned to basal levels, indicating that hormone release was not due to toxic effects on the CCK cells. Effects similar to those of A23187 were also achieved using 1 LM ionomycin. Control substances such as buffer alone, saline, and 1 ,uM bovine serum albumin had no effect on CCK release.
DISCUSSION
In the present study we used a specific CCK is the first luminal factor selective for stimulating CCK release to be purified and sequenced, to our knowledge, other CCK releasing factors appear to exist (13, 14, 31) . Furthermore, the relative physiologic importance of each type of releasing factor has yet to be determined. Characterization of specific releasing factors could be facilitated by the use of a pure population of responsive CCK cells.
Other approaches to studying CCK secretion in vitro have included enriching CCK cells by counterflow elutriation (20) and perfusion of isolated intestinal segments (18, 19) . Barber et al. (20) performed the first studies on isolated canine CCK cells, which were enriched =20-fold. Elevated extracellular potassium, dibutyryl cAMP, forskolin, and tryptophan were all shown to stimulate CCK release. The present data using a preparation of CCK cells enriched >100-fold support the findings that membrane depolarization with high concentrations of KCl stimulate CCK release. Furthermore, cAMP also appears to function as a second messenger pathway mediating CCK secretion since dibutyryl cAMP stimulated secretion from highly enriched CCK cells. Our studies with calcium ionophore have extended earlier observations by invoking intracellular calcium as an important intracellular regulator of CCK secretion. These findings raise the possibility that an increase in [Ca2+]i occurs by activation of the inositol phospholipid cascade through a membrane-receptorinitiated event (32, 33) . Additional studies on purified CCK cells should clarify the precise steps involved in CCK release.
Cuber et al. (18) have recently utilized an isolated vascularly perfused duodenojejunum from rat to study CCK secretion. Intraluminal administration of monitor peptide was found to stimulate CCK release (19) . A theoretical advantage of the intestinal segment model is that cells maintain their orientation to the luminal surface and potential secretagogues can be administered either intravascularly or on the luminal surface. These studies indicated that monitor peptide was acting on the luminal surface of the CCK cell to stimulate release.
Proc. Natl. Acad. Sci. USA 89 (1992) There are several advantages to studying a highly enriched population of hormone-secreting cells instead of a mixture of different cell types. The major advantage is that direct effects of secretagogues can be determined in a homogeneous population of CCK cells. In a mixed population of intestinal mucosal cells, it is extremely difficult to evaluate whether agents are acting directly on the CCK cell or indirectly on another cell type that in turn affects CCK secretion. In addition, an enriched population of CCK cells also provides a means for studying intracellular second messenger systems. By being able to measure enzyme and protein products that are activated or generated during secretagogue stimulation, this preparation of cells should be useful for studying stimulus-secretion coupling.
The ability of monitor peptide to stimulate CCK release from isolated CCK cells indicates that it is acting directly on the CCK cell. Because monitor peptide increases [Ca2+]i, it is likely that monitor peptide binds to membrane receptors. In animals, monitor peptide is found in pancreatic juice and is secreted into the lumen of the small intestine. Therefore, for monitor peptide to regulate CCK release in vivo, it is likely to interact with specific receptors on the luminal surface of the CCK cell. Further studies using autoradiographic techniques will be required to definitively address this issue.
